FLT3 Inhibitor Market Report: Trends, Forecast and Competitive Analysis

Trends, opportunities, and forecast in FLT3 inhibitor market to 2028 by therapy (type 1 FLT3 inhibitor and type 2 FLT3 inhibitor), drug type (midostaurin, gilteritinib, sorafenib, and others), pipeline product (crenolanib, dovitinib, and SKLB1028), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Published	Pages	Publisher	Report code
Jan 2023	150	Lucintel	ASDR-616550

Published: Jan 2023 - Pages : 150 - Publisher : Lucintel - Report code : ASDR-616550

Cullinan Oncology
Astellas Pharma
Allarity Therapeutics
AROG Pharmaceuticals
Aptose Biosciences
Novartis International
Daiichi Sankyo Company